This CME virtual expert panel discussion aims to enhance the knowledge and competence of cardiologists and other healthcare professionals managing patients with dyslipidemia and CV risk factors. Specifically, a panel of clinical experts will discuss the need for novel cholesterol therapies; describe the mechanisms of CETP inhibition in reducing CV risk; and review recent safety and efficacy data related to CETP inhibitors.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/cardiology/20240607/cetp-inhibitors-on-the-horizon-for-cardiovascular-risk-reduction/overview
- Start Date: 2024-06-14 05:00:00
- End Date: 2024-06-14 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: NewAmsterdam Pharma B.V. - Amount: 107586.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest